Constitutional function-improving agents
View Patent ↗The present invention is drawn to a method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising administering δ-aminolevulinic acid or a salt thereof every day in succession. The method further comprises administering at least one mineral.
1. A method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising:
identifying a vertebrate animal in need of increasing a weight of the vertebrate animal's thymus, wherein said vertebrate animal is a mammal or a bird, and
administering a dose of δ-aminolevulinic acid or a salt thereof every day in succession to maintain a constant effective amount of δ-aminolevulinic acid or a salt thereof sufficient to increase the weight of the vertebrate animal's thymus.
2. The method according to claim 1 , wherein δ-aminolevulinic acid or a salt thereof is a thymus cell growth agent.
3. The method according to claim 1 , wherein δ-aminolevulinic acid or salt thereof is co-administered with at least one mineral.
4. The method according to claim 3 , wherein the one mineral selected from the group consisting of iron, copper, selenium, zinc and manganese.
5. The method according to claim 2 , wherein δ-aminolevulinic acid or a salt thereof is administered orally, by injection, ophthalmically, as a suppository, by fomentation, in a patch, as an aerosol, via tube or by enteral ingestion.
6. The method according to claim 1 , wherein the δ-aminolevulinic acid or a salt thereof is added to a food or drink.
7. The method according to claim 1 , wherein the δ-aminolevulinic acid or a salt thereof is ingested in an amount of from 0.001 to 1000 mg per body weight per day.
8. The method according to claim 1 , wherein the vertebrate animal is a human.
9. The method according to claim 8 , wherein the human is at least 15 years old.
10. The method according to claim 1 , wherein said effective amount of δ-aminolevulinic acid or a salt thereof induces thymocyte proliferation.
11. The method according to claim 1 , wherein said period of time sufficient to increase the weight of the mammal's thymus is at least about one week.
12. The method according to claim 1 , wherein said period of time sufficient to increase the weight of the mammal's thymus is at least about four weeks.
13. A method of inducing thymocyte proliferation in a human with an impaired immune system comprising:
identifying a human in need of thymocyte proliferation, wherein said human is 15 years of age or older, and
administering continuously a dose of δ-aminolevulinic acid or a salt thereof every day to maintain a constant effective amount of δ-aminolevulinic acid or a salt thereof for a period of time sufficient to increase the weight of the human's thymus,
wherein said δ-aminolevulinic acid or a salt thereof is administered orally or by injection.
14. A method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system consisting of:
identifying a vertebrate animal in need of thymocyte proliferation, wherein said animal is a mammal or a bird, and
administering continuously a dose of δ-aminolevulinic acid or a salt thereof every day to maintain a constant effective amount of δ-aminolevulinic acid or a salt thereof for a period of time sufficient to increase the weight of the animal's thymus.
15. A method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising:
identifying a vertebrate animal in need of thymocyte proliferation, wherein said animal is a mammal or a bird, but not including a pig, and
administering continuously a dose of δ-aminolevulinic acid or a salt thereof every day to maintain a constant effective amount of δ-aminolevulinic acid or a salt thereof for a period of time sufficient to increase the weight of the animal's thymus.